In The Newsalzheon2024-08-09T11:20:07-04:00

In the News

Alzheon receives $47M NIH grant funding its phase III Alzheimer’s study

BioWorld

Boost for Alzheon’s targeted Alzheimer’s candidate

thepharmaletter.com

NIA Backs Alzheon’s Phase III Alzheimer’s Trial with $47 Million Grant

BioSpace

Targeting Amyloid Oligomers for Alzheimer’s Research

BioSpace

Is Targeting Oligomers in APOE4 Homozygotes the Path Forward in Alzheimer’s Disease?

NeurologyToday

Neurodegenerative Treatments Build to a Tipping Point

Genetic Engineering & Biotechnology News (GEN)

Alzheon Gets Closer to Alzheimer’s Drug Treatment

Cheddar

Take A Pill For It! Approach to Alzheimer’s Disease

Bloomer Boomer